Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001218460-10-000002)

Filing Details

Accession Number:: 0001218460-10-000002
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2010-10-25 15:08:25
Reporting Period:: 2010-03-31

Filing Date:: 2010-10-25
Accepted Time:: 2010-10-25 15:08:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1229089	Oncolin Therapeutics Inc.	OCOL	Pharmaceutical Preparations (2834)	880507007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218460	Kevan Casey	Po Box 87721 Houston TX 77287	Corp Secretary	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common	Disposition	2009-12-04	90,000,000	$0.00	343,167,694	No	5	S	Direct
Common	Disposition	2010-08-19	60,593,640	$0.00	282,574,054	No	4	S	Direct
Common	Disposition	2010-08-19	236,358,341	$0.00	46,215,713	No	4	S	Indirect	Voting Control

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	S	Direct
No	4	S	Direct
No	4	S	Indirect	Voting Control